Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Industry sector: Medical
Sector classification: Surgical & medical instruments
Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||0.74%|
|% Held by Institutions||90.30%|
|EPS (last reported FY)||$1.11|
|EPS (last reported Q)||$0.32|
|EPS, estimated (last reported Q)||$0.31|
|Total revenues||$8 B|
|Net income||$0 B|